Glazer Capital’s Pardes Biosciences PRDS Stock Holding History
Bought
Maintained
Sold
Other funds holding PRDS
JCM
C
Glazer Capital's PRDS Position: Q4 2021 in Review
Glazer Capital sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 265,631 shares — an estimated $2.64M sold.
Glazer Capital first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $8.89M in Q1 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.
- Glazer Capital reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
- Glazer Capital sold 265,631 Pardes Biosciences shares in Q4 2021, an estimated $2.64M.
- Glazer Capital first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
- Glazer Capital's Pardes Biosciences position peaked at $8.89M in Q1 2021.
- 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.
Based on Glazer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.